Hepatic fatty acid and glucose handling in metabolic disease: potential impact on cardiovascular disease risk

Hepatic fatty acid and glucose handling in metabolic disease: potential impact on cardiovascular disease risk

The prevalence of metabolic diseases, including type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing. Although invariably associated with obesity, the importance of fat deposition in non-adipose tissue organs has yet to be fully explored....

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Westcott, F, Dearlove, DJ, Hodson, L
Format:	Journal article
Sprog:	English
Udgivet:	Elsevier 2023

Lignende værker

Dietary fat quantity and composition influence hepatic lipid metabolism and metabolic disease risk in humans
af: Nikola Srnic, et al.
Udgivet: (2025-01-01)

Nutritional regulation of hepatic de novo lipogenesis in humans
af: Cross, E, et al.
Udgivet: (2023)

Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state
af: Hodson, L
Udgivet: (2018)

Adipose tissue fatty acid metabolism and cardiovascular disease.
af: Frayn, K, et al.
Udgivet: (2005)

Hepatic fatty acid partitioning.
af: Hodson, L, et al.
Udgivet: (2011)

Hepatic fatty acid partitioning
af: Hodson, L, et al.
Udgivet: (2011)

Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
af: Green, C, et al.
Udgivet: (2020)

Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
af: Michael Pavlides, et al.
Udgivet: (2020-08-01)

DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES
af: N. V. Perova, et al.
Udgivet: (2016-01-01)

Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions
af: Jung Il Lee
Udgivet: (2022-07-01)

Association of dietary fatty acids and the incidence risk of cardiovascular disease in adults: the Tehran Lipid and Glucose Prospective Study
af: Parvin Mirmiran, et al.
Udgivet: (2020-11-01)

Dietary fatty acids and cardiovascular disease
af: A.M. Salter
Udgivet: (2013-01-01)

Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
af: Xiao-Dong Zhou, et al.
Udgivet: (2022-12-01)

Relevance of human fat distribution on lipid and lipoprotein metabolism and cardiovascular disease risk
af: Piché, M, et al.
Udgivet: (2018)

Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease
af: Yingdong Lu, et al.
Udgivet: (2022-08-01)

Fatty Acid Binding Protein‐4 and Risk of Cardiovascular Disease: The Cardiovascular Health Study
af: Obiora Egbuche, et al.
Udgivet: (2020-04-01)

LDL fatty acids composition as a risk biomarker of cardiovascular disease
af: Hashem Nayeri, et al.
Udgivet: (2017-09-01)

Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk
af: O. M. Drapkina, et al.
Udgivet: (2016-09-01)

n-3 fatty acids and cardiovascular disease
af: Heidi Grundt, et al.
Udgivet: (2008-06-01)

Role of Polyunsaturated Fatty Acids in Cardiovascular Diseases
af: Mohammad Asif
Udgivet: (2015-10-01)

The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state
af: Hodson, L, et al.
Udgivet: (2019)

Coalescent inference for infectious disease: meta-analysis of hepatitis C.
af: Dearlove, B, et al.
Udgivet: (2013)

Coalescent inference for infectious disease: meta-analysis of hepatitis C
af: Dearlove, B, et al.
Udgivet: (2013)

Is there a role for omega-3 fatty acids in cardiovascular disease risk reduction?
af: R.Preston Mason, et al.
Udgivet: (2021-09-01)

Metabolic risk for cardiovascular disease /
af: Eckel, Robert H., et al.
Udgivet: (2011)

Relationship between Non-Alcoholic Fatty Liver Disease and Cardiovascular and Metabolic Risk Indices
af: Şevin Demir, et al.
Udgivet: (2022-07-01)

The importance of the fatty acid transporter L-carnitine in non-alcoholic fatty liver disease (NAFLD)
af: Savic, D, et al.
Udgivet: (2020)

Omega-3 fatty acid supplementation and cardiovascular disease
af: Donald B. Jump, et al.
Udgivet: (2012-12-01)

Dietary fatty acid patterns and risk of metabolic syndrome: Tehran lipid and glucose study
af: Parvin Mirmiran, et al.
Udgivet: (2023-09-01)

Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach
af: Karolina Drożdż, et al.
Udgivet: (2022-11-01)

The influence of dietary fatty acids on liver fat content and metabolism
af: Hodson, L, et al.
Udgivet: (2019)

Chronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult Mice.
af: Sebastian Brachs, et al.
Udgivet: (2016-01-01)

Prolyl-4-hydroxylase 3 maintains β cell glucose metabolism during fatty acid excess in mice
af: Daniela Nasteska, et al.
Udgivet: (2021-08-01)

MLX plays a key role in lipid and glucose metabolism in humans: evidence from in vitro and in vivo studies
af: Nagarajan, SR, et al.
Udgivet: (2023)

The risk of cardiovascular diseases in terms of the consumption of saturated fatty acids of plant and animal origin
af: Anna Wojda, et al.
Udgivet: (2021-03-01)

Dissociation between liver fat content and fasting metabolic markers of selective hepatic insulin resistance in humans
af: Westcott, F, et al.
Udgivet: (2024)

Fatty acid spillover: A signature of a metabolic health?
af: Piche, M, et al.
Udgivet: (2017)

A mitochondria-targeted fatty acid analogue influences hepatic glucose metabolism and reduces the plasma insulin/glucose ratio in male Wistar rats.
af: Carine Lindquist, et al.
Udgivet: (2019-01-01)

Hepatic‐Accumulated Obeticholic Acid and Atorvastatin Self‐Assembled Nanocrystals Potentiate Ameliorative Effects in Treatment of Metabolic‐Associated Fatty Liver Disease
af: Huanfen Lu, et al.
Udgivet: (2024-03-01)

Whole-body and hepatic dietary fatty acid oxidation is related to postprandial insulin concentrations in people with non-alcoholic fatty liver disease with varying degrees of insulin resistance
af: Hodson, L, et al.
Udgivet: (2013)